Transactions under Novozymes’ stock buyback program

As of June 26, Novozymes has purchased an accumulated 3,336,164 shares with a transaction value of DKK 841.3 million under the stock buyback program Novozymes announced in Company announcement No. 17, 2014 and initiated February 17, 2014.

​Under the program, Novozymes will buy back B shares worth up to DKK 2 billion in total during 2014.

The following transactions have been made under the program in accordance with the provisions of European Commission Regulation (EC) No. 2273/2003 of 22 December 2003, also referred to as the Safe Harbour Regulation: 

 
Number
 of shares
Average
purchase price
Transaction
value, DKK
Accumulated, last announcement
3,148,533
 
790,367,310
  June 20, 2014
35,807
274,54
9,830,404
  June 23, 2014
37,923
 274.37
10,404,925
  June 24, 2014
27,330
273.28
7,468,781
  June 25, 2014
44,571
 267.47
11,921,595
  June 26, 2014
42,000
268.33
11,269,859
Total accumulated under the program
3,336,164
 
841,262,874

  

In addition, transactions necessitated by Novozymes’ previously established incentive programs have resulted in a net sale by Novozymes of 10,027 B shares in the period from June 20 to June 26, 2014. The share transactions related to the incentive programs were not part of the Safe Harbour stock buyback program.

 

Following the transactions stated above, Novozymes owns a total of 7,481,455 treasury shares, corresponding to 2.3% of the stock capital. The total number of shares in the company is 319,700,000, including treasury shares.
 
Contact information
Investor Relations:
 
 
Thomas Bomhoff (DK)
+45 3077 1226
Klaus Sindahl (DK)
+45 5363 0134
Martin Riise (USA)
+1 919 649 2565
Press and media:
 
 
Rene Tronborg (DK)
+45 3077 2274
Frederik Bjoerndal (Europe)
+44 7976138265
Paige Donnelly (USA)
+1 919 218 4501
Meng Lian (China)
+86 136 9923 1164
Henrique Pellini (Brazil)
+55 41 9288 0282
Poonam Kapila (India)
+91 991 082 2339